Steven G. Charapata

1.5k total citations
8 papers, 948 citations indexed

About

Steven G. Charapata is a scholar working on Anesthesiology and Pain Medicine, Physiology and Cognitive Neuroscience. According to data from OpenAlex, Steven G. Charapata has authored 8 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Anesthesiology and Pain Medicine, 8 papers in Physiology and 3 papers in Cognitive Neuroscience. Recurrent topics in Steven G. Charapata's work include Pain Management and Opioid Use (8 papers), Pain Mechanisms and Treatments (8 papers) and Pain Management and Placebo Effect (3 papers). Steven G. Charapata is often cited by papers focused on Pain Management and Opioid Use (8 papers), Pain Mechanisms and Treatments (8 papers) and Pain Management and Placebo Effect (3 papers). Steven G. Charapata collaborates with scholars based in United States, United Kingdom and Ireland. Steven G. Charapata's co-authors include Mark S. Wallace, David Ellis, Robert B. Fisher, Dawn McGuire, Peter S. Staats, Michael G. Byas‐Smith, Martha Mayo, Lynn R. Webster, Thomas Yearwood and David A. Bryce and has published in prestigious journals such as JAMA, Pain and Anesthesia & Analgesia.

In The Last Decade

Steven G. Charapata

8 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven G. Charapata United States 8 548 510 268 189 180 8 948
Oleg Kambur Finland 12 109 0.2× 143 0.3× 91 0.3× 69 0.4× 85 0.5× 19 417
Karen M. Park United States 5 72 0.1× 222 0.4× 92 0.3× 28 0.1× 56 0.3× 7 455
Eileen C.P. Lim Singapore 10 290 0.5× 145 0.3× 63 0.2× 236 1.2× 172 1.0× 18 586
Jarkko Kalliomäki Sweden 12 38 0.1× 236 0.5× 56 0.2× 30 0.2× 55 0.3× 15 451
Kunie Nakajima Japan 7 56 0.1× 281 0.6× 56 0.2× 19 0.1× 85 0.5× 9 359
Masafumi Kimura Japan 12 44 0.1× 293 0.6× 83 0.3× 18 0.1× 103 0.6× 22 411
Ulla Bjerre Denmark 8 41 0.1× 241 0.5× 82 0.3× 13 0.1× 165 0.9× 8 626
Dyveke Demant Denmark 5 70 0.1× 360 0.7× 22 0.1× 25 0.1× 30 0.2× 7 432
Waltraud Binder Australia 9 45 0.1× 344 0.7× 200 0.7× 16 0.1× 55 0.3× 9 513
Ângela Maria Sousa Brazil 12 90 0.2× 215 0.4× 71 0.3× 24 0.1× 174 1.0× 31 441

Countries citing papers authored by Steven G. Charapata

Since Specialization
Citations

This map shows the geographic impact of Steven G. Charapata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven G. Charapata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven G. Charapata more than expected).

Fields of papers citing papers by Steven G. Charapata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven G. Charapata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven G. Charapata. The network helps show where Steven G. Charapata may publish in the future.

Co-authorship network of co-authors of Steven G. Charapata

This figure shows the co-authorship network connecting the top 25 collaborators of Steven G. Charapata. A scholar is included among the top collaborators of Steven G. Charapata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven G. Charapata. Steven G. Charapata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Webster, Lynn R., Robert B. Fisher, Steven G. Charapata, & Mark S. Wallace. (2008). Long-Term Intrathecal Ziconotide for Chronic Pain: An Open-Label Study. Journal of Pain and Symptom Management. 37(3). 363–372. 45 indexed citations
2.
Ellis, David, Sanjeeva Dissanayake, Dawn McGuire, et al.. (2008). Continuous Intrathecal Infusion of Ziconotide for Treatment of Chronic Malignant and Nonmalignant Pain Over 12 Months: A Prospective, Open-label Study. Neuromodulation Technology at the Neural Interface. 11(1). 40–49. 40 indexed citations
3.
Wallace, Mark S., Richard Rauck, Robert B. Fisher, et al.. (2008). Intrathecal Ziconotide for Severe Chronic Pain: Safety and Tolerability Results of an Open-Label, Long-Term Trial. Anesthesia & Analgesia. 106(2). 628–637. 67 indexed citations
5.
Wallace, Mark S., Steven G. Charapata, Robert B. Fisher, et al.. (2006). Intrathecal Ziconotide in the Treatment of Chronic Nonmalignant Pain: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Neuromodulation Technology at the Neural Interface. 9(2). 75–86. 130 indexed citations
6.
Rauck, Richard, Mark S. Wallace, Michael S. Leong, et al.. (2006). A Randomized, Double-Blind, Placebo-Controlled Study of Intrathecal Ziconotide in Adults with Severe Chronic Pain. Journal of Pain and Symptom Management. 31(5). 393–406. 184 indexed citations
7.
Staats, Peter S., Thomas Yearwood, Steven G. Charapata, et al.. (2004). Intrathecal Ziconotide in the Treatment of Refractory Pain in Patients With Cancer or AIDS. JAMA. 291(1). 63–63. 404 indexed citations
8.
Reynolds, Lowell W., Richard Rauck, Lynn R. Webster, et al.. (2004). Relative analgesic potency of fentanyl and sufentanil during intermediate-term infusions in patients after long-term opioid treatment for chronic pain. Pain. 110(1). 182–188. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026